nasal spray News
Most Popular nasal spray Story
Meda shells out $800M for MedPointe
Sweden's Meda has purchased U.S.-based MedPointe in an $800 million cash and stock deal. Meda said that MedPointe's products, which focus on the areas of allergy, respiratory and pain, are a perfect... Read more...
Latest Headlines
- April 23, 2008
- November 7, 2007
- July 20, 2007
- December 5, 2006
- August 14, 2006
- March 2, 2006
- March 1, 2006
- February 1, 2006
- December 6, 2005
- November 30, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
